These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6503214)

  • 21. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
    Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY
    Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal clonidine therapy in hypertensive patients. Effects on office and ambulatory recorded blood pressure values.
    Schaller MD; Nussberger J; Waeber B; Porchet M; Brunner HR
    JAMA; 1985 Jan; 253(2):233-5. PubMed ID: 3965774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rebound hypertension associated with transdermal clonidine and contact dermatitis.
    White TM; Guidry JR
    West J Med; 1986 Jul; 145(1):104. PubMed ID: 3751022
    [No Abstract]   [Full Text] [Related]  

  • 24. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal administration of clonidine for treatment of high BP.
    Weber MA; Drayer JI; McMahon FG; Hamburger R; Shah AR; Kirk LN
    Arch Intern Med; 1984 Jun; 144(6):1211-3. PubMed ID: 6375613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Contact allergy to clonidine-TTS].
    van Ketel WG
    Ned Tijdschr Geneeskd; 1984 Jan; 128(1):34-5. PubMed ID: 6694765
    [No Abstract]   [Full Text] [Related]  

  • 27. The USA experience with the clonidine transdermal therapeutic system.
    Burris JF
    Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal clonidine for hypertensive patients.
    Popli S; Stroka G; Ing TS; Daugirdas JT; Norusis MJ; Hano JE; Gandhi VC
    Clin Ther; 1983; 5(6):624-8. PubMed ID: 6627288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience.
    Lowenthal DT; Saris S; Paran E; Cristal N; Sharif K; Bies C; Fagan T
    Am Heart J; 1986 Oct; 112(4):893-900. PubMed ID: 3532747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal clonidine in the treatment of adolescent hypertension.
    Falkner B; Thanki B; Lowenthal DT
    J Hypertens Suppl; 1985 Dec; 3(4):S61-3. PubMed ID: 3868713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal clonidine in mild hypertension. A randomized, double-blind, placebo-controlled trial.
    Popli S; Daugirdas JT; Neubauer JA; Hockenberry B; Hano JE; Ing TS
    Arch Intern Med; 1986 Nov; 146(11):2140-4. PubMed ID: 3535714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system.
    Weber MA; Drayer JI
    Am Heart J; 1984 Jul; 108(1):231-6. PubMed ID: 6375331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonidine: irritant and allergic contact dermatitis assays.
    Maibach H
    Contact Dermatitis; 1985 Apr; 12(4):192-5. PubMed ID: 4017566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of contact dermatitis associated with transdermal therapeutic systems.
    Holdiness MR
    Contact Dermatitis; 1989 Jan; 20(1):3-9. PubMed ID: 2492460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressive effects of transdermal clonidine administration on contact hypersensitivity reactions in guinea pigs.
    Goeptar AR; de Groot J; Lang M; van Tol RG; Scheper RJ
    Int J Immunopharmacol; 1988; 10(3):277-82. PubMed ID: 3182151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transdermal therapy of arterial hypertension: a new approach in the management of hypertensive patients].
    Ambrosioni E
    Ann Ital Med Int; 1994 Oct; 9 Suppl():54S-57S. PubMed ID: 7857759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
    McMahon FG; Jain AK; Vargas R; Fillingim J
    Clin Ther; 1990; 12(2):88-100. PubMed ID: 2191779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of two-year therapy with transdermal clonidine for essential hypertension.
    Horning JR; Zawada ET; Simmons JL; Williams L; McNulty R
    Chest; 1988 May; 93(5):941-5. PubMed ID: 3282823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension.
    Davies SF; Graif JL; Husebye DG; Maddy MM; McArthur CD; Path MJ; O'Connell MB; Iber C; Davidman M
    Arch Intern Med; 1989 Jul; 149(7):1551-6. PubMed ID: 2525897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Langley MS; Heel RC
    Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.